Status:
RECRUITING
HPC Offered for PRESERVE Expansion
Lead Sponsor:
Ossium Health, Inc.
Conditions:
Bone Marrow Transplant (BMT)
Eligibility:
All Genders
12-80 years
Brief Summary
Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if:
- Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks
Exclusion
Key Trial Info
Start Date :
June 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2029
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT07145411
Start Date
June 27 2024
End Date
August 1 2029
Last Update
August 28 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama, Birmingham
Birmingham, Alabama, United States, 35294
2
Henry Ford Health
Detroit, Michigan, United States, 48202
3
The Ohio State University Medical Center
Columbus, Ohio, United States, 43210
4
Tristar Centennial Medical Center
Nashville, Tennessee, United States, 37203